BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20150592)

  • 21. [Genetically encoded FRET-pair on the basis of terbium-binding peptide and red fluorescent protein].
    Arslanbaeva LR; Zherdeva VV; Ivashina TV; Vinokurov LM; Rusanov AL; Savitskiĭ AP
    Prikl Biokhim Mikrobiol; 2010; 46(2):166-71. PubMed ID: 20391759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Dual Readout Assay Based on Fluorescence Polarization and Time-Resolved Fluorescence Resonance Energy Transfer to Screen for RSK1 Inhibitors.
    Jeong EM; Lee MY; Lee JH; Lee BH; Oh KS
    Biol Pharm Bull; 2016; 39(4):547-55. PubMed ID: 27040627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of heterotrimeric G-protein and regulators of G-protein signaling interactions by time-resolved fluorescence resonance energy transfer.
    Leifert WR; Bailey K; Cooper TH; Aloia AL; Glatz RV; McMurchie EJ
    Anal Biochem; 2006 Aug; 355(2):201-12. PubMed ID: 16729956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A directly labeled TR-FRET assay for monitoring phosphoinositide-3-kinase activity.
    Yang X; Li P; Feldberg L; Kim SC; Bowman M; Hollander I; Mallon R; Wolf SF
    Comb Chem High Throughput Screen; 2006 Aug; 9(7):565-70. PubMed ID: 16925516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A genetically encoded fluorescent indicator capable of discriminating estrogen agonists from antagonists in living cells.
    Awais M; Sato M; Sasaki K; Umezawa Y
    Anal Chem; 2004 Apr; 76(8):2181-6. PubMed ID: 15080726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential recruitment of co-regulatory proteins to the human estrogen receptor 1 in response to xenoestrogens.
    Smith LC; Clark JC; Bisesi JH; Ferguson PL; Sabo-Attwood T
    Comp Biochem Physiol Part D Genomics Proteomics; 2016 Sep; 19():159-173. PubMed ID: 27156127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In pursuit of synthetic modulators for the orphan retina-specific nuclear receptor NR2E3.
    Qin Q; Knapinska A; Dobri N; Madoux F; Chase P; Hodder P; Petrukhin K
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):298-309. PubMed ID: 23098562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-resolved fluorescence ligand binding for G protein-coupled receptors.
    Emami-Nemini A; Roux T; Leblay M; Bourrier E; Lamarque L; Trinquet E; Lohse MJ
    Nat Protoc; 2013; 8(7):1307-20. PubMed ID: 23764938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-label time-resolved luminescence assay for estrogen receptor--ligand binding.
    Huttunen R; Shweta ; Martikkala E; Lahdenranta M; Virta P; Hänninen P; Härmä H
    Anal Biochem; 2011 Aug; 415(1):27-31. PubMed ID: 21477578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of BODIPY FL Thalidomide As a High-Affinity Fluorescent Probe for Cereblon in a Time-Resolved Fluorescence Resonance Energy Transfer Assay.
    Lin W; Li Y; Min J; Liu J; Yang L; Lee RE; Chen T
    Bioconjug Chem; 2020 Nov; 31(11):2564-2575. PubMed ID: 33070611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A short-incubation reporter-gene assay for high-throughput screening of estrogen receptor-alpha antagonists.
    Shi X; Zheng W; Schneeweis JE; Fischer PA; Strulovici B; Peekhaus NT
    Assay Drug Dev Technol; 2005 Aug; 3(4):393-400. PubMed ID: 16180994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovering small-molecule estrogen receptor α/coactivator binding inhibitors: high-throughput screening, ligand development, and models for enhanced potency.
    Sun A; Moore TW; Gunther JR; Kim MS; Rhoden E; Du Y; Fu H; Snyder JP; Katzenellenbogen JA
    ChemMedChem; 2011 Apr; 6(4):654-66. PubMed ID: 21365764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a High-Throughput Assay for Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1 Based on Time-Resolved Fluorescence Energy Transfer.
    Kim TG; Lee JH; Lee MY; Kim KU; Lee JH; Park CH; Lee BH; Oh KS
    Biol Pharm Bull; 2017; 40(9):1454-1462. PubMed ID: 28867728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplexing terbium- and europium-based TR-FRET readouts to increase kinase assay capacity.
    Horton RA; Vogel KW
    J Biomol Screen; 2010 Sep; 15(8):1008-15. PubMed ID: 20460248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.
    Lee G; Elwood F; McNally J; Weiszmann J; Lindstrom M; Amaral K; Nakamura M; Miao S; Cao P; Learned RM; Chen JL; Li Y
    J Biol Chem; 2002 May; 277(22):19649-57. PubMed ID: 11877444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.
    Ozers MS; Ervin KM; Steffen CL; Fronczak JA; Lebakken CS; Carnahan KA; Lowery RG; Burke TJ
    Mol Endocrinol; 2005 Jan; 19(1):25-34. PubMed ID: 15375189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.
    Kallen J; Schlaeppi JM; Bitsch F; Filipuzzi I; Schilb A; Riou V; Graham A; Strauss A; Geiser M; Fournier B
    J Biol Chem; 2004 Nov; 279(47):49330-7. PubMed ID: 15337744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a.
    Leyris JP; Roux T; Trinquet E; Verdié P; Fehrentz JA; Oueslati N; Douzon S; Bourrier E; Lamarque L; Gagne D; Galleyrand JC; M'kadmi C; Martinez J; Mary S; Banères JL; Marie J
    Anal Biochem; 2011 Jan; 408(2):253-62. PubMed ID: 20937574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-Resolved FRET-Based Assays to Characterize G Protein-Coupled Receptor Hetero-oligomer Pharmacology.
    Heuninck J; Hounsou C; Dupuis E; Trinquet E; Mouillac B; Pin JP; Bonnet D; Durroux T
    Methods Mol Biol; 2019; 1947():151-168. PubMed ID: 30969415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.